Author

G. Cohen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1 Microbiology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

F. I. Ibukun· 2 shared S. Krummey· 2 shared A. Arner· 1 shared A. Silvani· 1 shared C. Beerli· 1 shared C. Berteotti· 1 shared C. Strain-Damerell· 1 shared Covid-Moonshot Consortium· 1 shared

Activity by Year

2017-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. I. Ibukun

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Marginal Zone B cells are Necessary for the Formation of Anti-Donor IgG After Allogeneic Sensitization

M. A. Kallarakal, G. Cohen, F. I. Ibukun, S. Krummey

This study shows that marginal zone B cells are crucial for forming anti-donor IgG after allogeneic sensitization and for generating germinal center B cells.

bioRxiv · Sep 23, 2022Immunology

Transplantation Elicits a Clonally Diverse CD8+ T Cell Response That is Comprised of Potent CD43+ Effectors

G. Cohen, M. Kallarakal, S. Jayaraman, F. I. Ibukun, K. P. Tong, L. D. Orzolek, H. B. Larman, S. Krummey

This study identifies CD43+ effector CD8+ T cells as potent responders after transplantation, showing their distinct profile and the importance of CD43 and ICOS in graft survival.

bioRxiv · May 21, 2022Immunology

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor.

D. Zaidman, P. Gehrtz, M. Filep, D. Fearon, J. Prilusky, S. Duberstein, G. Cohen, D. Owen, E. Resnick, C. Strain-Damerell, P. Lukacik, Covid-Moonshot Consortium, H. Barr, M. A. Walsh, F. von Delft, N. London

The paper introduces a computational pipeline to design irreversible inhibitors, identifying a potent SARS-CoV-2 Mpro inhibitor with low micromolar IC50.

Cell Chemical Biology · Dec 1, 2021Peer-reviewedBiochemistry

Nanoscale Polarization of the Vaccinia Virus Entry Fusion Complex Drives Efficient Fusion

R. Gray, D. Albrecht, C. Beerli, G. Cohen, R. Henriques, J. Mercer

This study uses super-resolution microscopy to show that vaccinia virus fusion proteins are polarized at virion tips, and disrupting this polarization reduces fusion efficiency.

bioRxiv · Jul 1, 2018Microbiology

Long-term cardiovascular re-programming by short-term perinatal exposure to nicotine‘s main metabolite cotinine

S. Bastianini, V. Lo Martire, A. Silvani, G. Zoccoli, C. Berteotti, H. Lagercrantz, A. Arner, G. Cohen

This study shows that perinatal exposure to cotinine, a nicotine metabolite, causes long-term cardiovascular changes in mice, suggesting potential developmental risks.

bioRxiv · Sep 23, 2017Physiology